Bionano Genomics, Inc.
Nasdaq · Technology · Laboratory Analytical Instruments · San Diego, CA
BNGO chart
What traders are saying about $BNGO
Latest postsBionano Genomics, Inc. news
- Bionano to Report Third Quarter 2026 Financial Results and Host a Conference Call Webcast on November 10, 2026
Yahoo Finance ·
- Bionano Genomics, Inc. Estimates – BOATS:BNGO
TradingView ·
- BNGO Q3'26 Earnings: revenue estimate is 8.44M USD
TradingView ·
- Bionano Laboratories Announces Expansion of Diagnostic Testing Based on Optical Genome Mapping for Hematologic Malignancies
Yahoo Finance ·
- Bionano Announces Three New Peer-Reviewed Studies Demonstrate Clinical Value of Bionano's Optical Genome Mapping Across Myelodysplastic Syndromes and Acute Myeloid Leukemia
Yahoo Finance ·
- Bionano Laboratories Announces Proposed Local Coverage Determination (LCD) from MolDX for Genome-Wide Detection of Structural Variants in Hematologic Neoplasms
Yahoo Finance ·
- Bionano Laboratories Announces New York State Department of Health Approval of Lab Developed Tests Based on Optical Genome Mapping
Yahoo Finance ·
- Bionano to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Yahoo Finance ·
- Bionano Genomics (BNGO) Q2 2026 Earnings Call Transcript
fool.com ·
- Bionano Genomics Inc (BNGO) (Q2 2026) Earnings Call Highlights: Record Flow Cell Sales and ...
Yahoo Finance ·
- Bionano Genomics, Inc. Q2 2026 Earnings Call Summary
app.moby.co ·
- Bionano Reports Second Quarter 2026 Results and Provides a Business Update
Yahoo Finance ·
Bionano Genomics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $28.5M | $30.8M | $36.1M | $27.8M |
| Net income | -$26.4M | -$112.0M | -$232.5M | -$132.6M |
| Diluted EPS | $-4.85 | $-88.13 | $-408.60 | $-4.58 |
| Total assets (year end) | $73.6M | $76.7M | $214.4M | $307.5M |
| Cash and equivalents (year end) | $3.0M | $9.2M | $17.9M | $5.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Bionano Genomics, Inc.
- Ticker
- BNGO (Nasdaq)
- Industry
- Laboratory Analytical Instruments
- Headquarters
- San Diego, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1411690
- Former names
- BioNano Genomics, Inc, Bionano Genomics, Inc, BioNanomatrix Inc
Frequently asked questions
What exchange is Bionano Genomics, Inc. listed on?
Bionano Genomics, Inc. trades on the Nasdaq under the ticker symbol BNGO.
What industry is Bionano Genomics, Inc. in?
Bionano Genomics, Inc. is classified by the SEC under "Laboratory Analytical Instruments", part of the Technology sector on StockTweeting.
Where is Bionano Genomics, Inc. headquartered?
Bionano Genomics, Inc.'s business address on file with the SEC is in San Diego, CA.
When does Bionano Genomics, Inc.'s fiscal year end?
Bionano Genomics, Inc.'s fiscal year ends on December 31.
How much revenue did Bionano Genomics, Inc. report?
Bionano Genomics, Inc. reported $28.5M in revenue for calendar year 2025, according to its SEC filings.